| Product Name | MF | CAS | Details |
|---|
| (Rac)-5-Keto Fluvastatin | C24H24FNO4 | 1160169-39-0 | Details |
| Beta-Lipotropin (1-10), porcine Acetate, 10 mM in DMSO | Details |
| SY-640 | C11H13NO3 | 168705-70-2 | Details |
| NPS ALX Compound 4a hydrochloride(1:1) | Details |
| 2,3-dihydrothieno-Thiadiazole Carboxylate | C6H4N2O2S2 | 152467-47-5 | Details |
| SYM2206, 10 mM in DMSO | C20H22N4O3 | 173952-44-8 | Details |
| SZL P1-41, 10 mM in DMSO | C24H24N2O3S | 222716-34-9 | Details |
| Beta-Lipotropin (1-10), porcine Acetate | Details |
| AZ 11645373, 10 mM in DMSO | C24H21N3O5S | 227088-94-0 | Details |
| eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) (387-394) [Multiple species]（TFA) | Details |
| Cl-C6-PEG4-O-CH2COOH | C16H31ClO7 | 1799506-30-1 | Details |
| Carcinine ditrifluoroacetate Acetate | C8H14N4O | 56897-53-1 | Details |
| T025, 10 mM in DMSO | C21H18N8 | 2407433-00-3 | Details |
| Azepexole hydrochloride, 10 mM in DMSO | C9H16ClN3O | 147663-20-5 | Details |
| (4R)-RO5263397 | C10H11FN2O | 1357266-80-8 | Details |
| T16Ainh-A01 | C19H20N4O3S2 | 552309-42-9 | Details |
| Propargyl-PEG17-methane | C36H70O17 | 2169967-47-7 | Details |
| Aspartyl-alanyl-diketopiperazine acetate, 10 mM in DMSO | Details |
| Bax inhibitor peptide V5 acetate, 10 mM in DMSO | Details |
| diABZI STING agonist-1 (Tautomerism) | C42H51N13O7 | 2138498-18-5 | Details |
| Acetyl Angiotensinogen (1-14), porcine Acetate, 10 mM in DMSO | Details |
| FBPase-1 inhibitor-1, 10 mM in DMSO | C13H7Cl3N2O3S | 883973-99-7 | Details |
| SY-5609, 10 mM in DMSO | C23H26F3N6OP | 2417302-07-7 | Details |
| NPS ALX Compound 4a hydrochloride(1:1), 10 mM in DMSO | Details |
| VH032-cyclopropane-F, 10 mM in DMSO | C26H33FN4O5S | 2306193-99-5 | Details |
| Anti-Inflammatory Peptide 1 Acetate, 10 mM in DMSO | Details |
| Syntide 2 acetate(108334-68-5 free base) | Details |
| T0070907, 10 mM in DMSO | C12H8ClN3O3 | 313516-66-4 | Details |
| GnRH Associated Peptide (GAP) (1-13), human Acetate, 10 mM in DMSO | Details |
| CPI-0610 carboxylic acid | C20H15ClN2O3 | 1380089-81-5 | Details |
| SMARCA-BD ligand 1 for Protac dihydrochloride | C14H18ClN5O | 2369053-68-7 | Details |
| Syk Inhibitor II hydrochloride, 10 mM in DMSO | C14H16ClF3N6O | 2490508-82-0 | Details |
| Omeprazole metabolite Omeprazole sulfone | C17H19N3O4S | 88546-55-8 | Details |
| Epidermal Growth Factor Receptor Peptide Acetate, 10 mM in DMSO | Details |
| SXC 2023 | C13H15NO4S | 1695562-36-7 | Details |
| N-(2-Chloro-6-methylphenyl)-N''-4-pyridinylurea, 10 mM in DMSO | C13H12ClN3O | 97627-24-2 | Details |
| Thalidomide-O-amido-C6-NH2 TFA, 10 mM in DMSO | C23H27F3N4O8 | 1950635-14-9 | Details |
| Thalidomide-O-amido-C6-NH2 hydrochloride | C21H27ClN4O6 | 2376990-31-5 | Details |
| SynuClean-D, 10 mM in DMSO | C13H5F3N4O5 | 685121-45-3 | Details |
| SYP-5, 10 mM in DMSO | C18H16O3S | 1384268-04-5 | Details |
| N-Desethyl Chloroquine Hydrochloride | C16H23Cl2N3 | 15912-96-6 | Details |
| Cytochrome c - pigeon (88-104) Acetate | Details |
| T-0509 | C18H23NO5 | 96843-99-1 | Details |
| SYM 2081 | C6H11NO4 | 31137-74-3 | Details |
| T-00127_HEV1, 10 mM in DMSO | C22H29N5O3 | 900874-91-1 | Details |
| I-OMe-Tyrphostin AG 538, 10 mM in DMSO | C17H12INO5 | 1094048-77-7 | Details |
| NOT Receptor Modulator 1, 10 mM in DMSO | C22H19ClN2O | 1015231-98-7 | Details |
| β-Interleukin I (163-171), human Acetate, 10 mM in DMSO | Details |
| SW155246, 10 mM in DMSO | C16H11ClN2O5S | 420092-79-1 | Details |
| SX-682, 10 mM in DMSO | C19H14BF4N3O4S | 1648843-04-2 | Details |
| Mal-PEG1-Val-Cit-OH | Details |
| T-1095, 10 mM in DMSO | C26H28O11 | 209746-59-8 | Details |
| Dabigatran ethyl ester hydrochloride, 10 mM in DMSO | C27H30ClN7O3 | 211914-50-0 | Details |
| PKA inhibitor fragment (6-22) amide Acetate | Details |
| Epidermal Growth Factor Receptor Peptide Acetate | Details |
| SW-100, 10 mM in DMSO | C17H17ClN2O2 | 2126744-35-0 | Details |
| AZ-Dyrk1B-33, 10 mM in DMSO | C19H16N4 | 1679330-37-0 | Details |
| Thalidomide-O-amido-PEG-C2-NH2 hydrochloride, 10 mM in DMSO | C19H23ClN4O7 | 2204226-02-6 | Details |
| Desformylflustrabromine hydrochloride | C16H22BrClN2 | 951322-11-5 | Details |
| Syk Inhibitor II dihydrochloride, 10 mM in DMSO | C14H16ClF3N6O | 227449-73-2 | Details |
| (S,R,S)-AHPC-PEG4-N3 | C32H47N7O8S | 1797406-81-5 | Details |
| SW106065, 10 mM in DMSO | C10H8N2OS | 62289-81-0 | Details |
| 1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine | C40H80NO8P | 76343-22-1 | Details |
| Vipivotide tetraxetan | C49H71N9O16 | 1702967-37-0 | Details |
| β-Interleukin I (163-171), human Acetate | Details |
| Dynamin inhibitory peptide Acetate | Details |
| Systemin acetate(137181-56-7 free base) | Details |
| Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate | C27H36N2O4 | 2725484-87-5 | Details |
| GnRH Associated Peptide (GAP) (1-13), human Acetate | C65H101N15O25 | 100111-07-7 | Details |
| (S,R,S)-AHPC-PEG4-NH2 | C32H49N5O8S | 2010159-57-4 | Details |
| Acetyl Angiotensinogen (1-14), porcine Acetate | Details |
| Ac-Endothelin-1 (16-21), human acetate | Details |
| 4-Azido-L-phenylalanine hydrochloride, 10 mM in DMSO | C9H11ClN4O2 | 34670-43-4 | Details |
| SB399885, 10 mM in DMSO | C18H21Cl2N3O4S | 402713-80-8 | Details |
| SW2_110A | C42H60N6O7 | 2579696-95-8 | Details |
| T0901317, 10 mM in DMSO | C17H12F9NO3S | 293754-55-9 | Details |
| PKA inhibitor fragment (6-22) amide Acetate, 10 mM in DMSO | Details |
| Dimebolin, 10 mM in DMSO | C21H25N3 | 3613-73-8 | Details |
| 1-Oleoyl lysophosphatidic acid sodium | C21H40NaO7P | 325465-93-8 | Details |
| (2R,3S)-Azelaprag | 2049979-31-7 | Details |
| T-1101 tosylate, 10 mM in DMSO | C31H31N5O6S3 | 2250404-95-4 | Details |
| Bax inhibitor peptide V5 acetate | Details |
| Beta-Sheet Breaker Peptide iAβ5 Acetate, 10 mM in DMSO | Details |
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride | C30H46ClN5O7S | 2097971-11-2 | Details |
| Dihydroxyacetone phosphate hemimagnesium salt hydrate | Details |
| 1-(1-Naphthyl) piperazine hydrochloride, 10 mM in DMSO | C14H17ClN2 | 104113-71-5 | Details |
| SW033291, 10 mM in DMSO | C21H20N2OS3 | 459147-39-8 | Details |
| SYR127063, 10 mM in DMSO | C23H20ClF3N4O3 | 871026-18-5 | Details |
| T-0156 | C31H29N5O7 | 324572-92-1 | Details |
| T-2000 | C20H20N2O5 | 97846-21-4 | Details |
| UK 227786, 10 mM in DMSO | C22H21ClN4O4.ClH | 150452-21-4 | Details |
| Beta-Sheet Breaker Peptide iAβ5 Acetate | Details |
| Dynamin inhibitory peptide Acetate, 10 mM in DMSO | Details |
| SW044248, 10 mM in DMSO | C22H23N5O2S | 522650-83-5 | Details |
| Syk Inhibitor II, 10 mM in DMSO | C14H15F3N6O | 726695-51-8 | Details |
| Synta66, 10 mM in DMSO | C20H17FN2O3 | 835904-51-3 | Details |
| 2,3,4,6-Tetra-o-acetyl-alpha-galactosylpyranosyl bromide | C14H19BrO9 | 529493-92-3 | Details |
| DMAB-anabaseine dihydrochloride | C19H22ClN3 | 154149-38-9 | Details |
| Anti-Inflammatory Peptide 1 Acetate | Details |
| Cytochrome c - pigeon (88-104) Acetate, 10 mM in DMSO | Details |
| Product Total： Product Page： | ||||
| 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 | ||||